Literature DB >> 16465546

The properties of recombinant Sendai virus having the P gene of Sendai virus pi strain derived from BHK cells persistently infected with Sendai virus.

Machiko Nishio1, Ai Nagata, Ayako Yamamoto, Masato Tsurudome, Morihiro Ito, Mitsuo Kawano, Hiroshi Komada, Yasuhiko Ito.   

Abstract

We prepared the chimeric recombinant Sendai virus [rSeV(Ppi)] by replacing the P gene of the Z strain with that of pi strain for analyzing the function of Ppi, Vpi and Cpi proteins. Intriguingly, HA production by rSeV(Ppi) is significantly lower at 38 degrees C than at 32 degrees C, showing that virus growth of rSeV(Ppi) is slightly suppressed at 38 degrees C. However, the main phenotypes of SeVpi, a marked temperature sensitivity as viral replication and an ability of establishing persistent infection, are not explained by the Ppi, Vpi and Cpi proteins. The V and C proteins form inclusion bodies in L929 cells infected with rSeV(Ppi) and incubated at 38 degrees C. L929 cells infected with rSeV(Ppi) and L929 cells stably expressing the Cpi protein show resistance to interferon-beta at 32 and 38 degrees C, indicating that the Cpi protein per se is not temperature-sensitive to inhibition of IFN signaling. The complete genome sequences of Sendai virus (SeV) pi and parent Nagoya strains were determined. Fifty nucleic acid substitutions are found in the genome sequence of SeV pi strain in comparison with Nagoya strain. There are three nucleic acid substitutions in the leader sequence, while the trailer, intergenic, gene-end and gene-start sequences of both strains are completely identical. Deletions and insertions of nucleotide are not found. There are 32 amino acid substitutions in Sendai virus pi strain. The specific amino acid substitutions unique to the SeVpi are 18. Information about the complete genome sequences of SeVpi strain is important to totally understand the persistent infection and lower pathogenicity of SeV.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16465546     DOI: 10.1007/s00430-006-0012-3

Source DB:  PubMed          Journal:  Med Microbiol Immunol        ISSN: 0300-8584            Impact factor:   3.402


  14 in total

1.  MULTIPLICATION OF A MYXOVIRUS (SV5) WITH MINIMAL CYTOPATHIC EFFECTS AND WITHOUT INTERFERENCE.

Authors:  P W CHOPPIN
Journal:  Virology       Date:  1964-06       Impact factor: 3.616

2.  Interferon susceptibility of various cell lines persistently infected with haemagglutinating virus of Japan (HVJ).

Authors:  Y Ito; Y Nishiyama; K Shimokata; I Nagata; A Kunii
Journal:  J Gen Virol       Date:  1979-04       Impact factor: 3.891

3.  Temperature sensitivity of interferon susceptibility in L cells persistently infected with hemagglutinating virus of Japan (HVJ).

Authors:  Y Ito; Y Nishiyama; K Shimokata; I Nagata; A Kunii
Journal:  Virology       Date:  1978-08       Impact factor: 3.616

4.  Temperature-sensitive phenomenon of viral maturation observed in BHK cells persistently infected with HVJ.

Authors:  I Nagata; Y Kimura; Y Ito; T Tanaka
Journal:  Virology       Date:  1972-08       Impact factor: 3.616

5.  Persistent infection by a temperature-sensitive mutant isolated from a Sendai virus (HVJ) carrier culture: its initiation and maintenance without aid of defective interfering particles.

Authors:  T Yoshida; M Hamaguchi; H Naruse; Y Nagai
Journal:  Virology       Date:  1982-07-30       Impact factor: 3.616

6.  Sendai virus C proteins counteract the interferon-mediated induction of an antiviral state.

Authors:  D Garcin; P Latorre; D Kolakofsky
Journal:  J Virol       Date:  1999-08       Impact factor: 5.103

7.  Recombinant Sendai viruses with L1618V mutation in their L polymerase protein establish persistent infection, but not temperature sensitivity.

Authors:  Machiko Nishio; Ai Nagata; Masato Tsurudome; Morihiro Ito; Mitsuo Kawano; Hiroshi Komada; Yasuhiko Ito
Journal:  Virology       Date:  2004-11-24       Impact factor: 3.616

8.  Knockout of the Sendai virus C gene eliminates the viral ability to prevent the interferon-alpha/beta-mediated responses.

Authors:  B Gotoh; K Takeuchi; T Komatsu; J Yokoo; Y Kimura; A Kurotani; A Kato; Y Nagai
Journal:  FEBS Lett       Date:  1999-10-08       Impact factor: 4.124

9.  Involvement of the leader sequence in Sendai virus pathogenesis revealed by recovery of a pathogenic field isolate from cDNA.

Authors:  Yutaka Fujii; Takemasa Sakaguchi; Katsuhiro Kiyotani; Cheng Huang; Noriko Fukuhara; Yoshiko Egi; Tetsuya Yoshida
Journal:  J Virol       Date:  2002-09       Impact factor: 5.103

10.  A highly recombinogenic system for the recovery of infectious Sendai paramyxovirus from cDNA: generation of a novel copy-back nondefective interfering virus.

Authors:  D Garcin; T Pelet; P Calain; L Roux; J Curran; D Kolakofsky
Journal:  EMBO J       Date:  1995-12-15       Impact factor: 11.598

View more
  2 in total

1.  Newcastle Disease Virus Establishes Persistent Infection in Tumor Cells In Vitro: Contribution of the Cleavage Site of Fusion Protein and Second Sialic Acid Binding Site of Hemagglutinin-Neuraminidase.

Authors:  Udaya S Rangaswamy; Weijia Wang; Xing Cheng; Patrick McTamney; Danielle Carroll; Hong Jin
Journal:  J Virol       Date:  2017-07-27       Impact factor: 5.103

2.  Virus susceptibility of Chinese hamster ovary (CHO) cells and detection of viral contaminations by adventitious agent testing.

Authors:  Andreas Berting; Maria R Farcet; Thomas R Kreil
Journal:  Biotechnol Bioeng       Date:  2010-07-01       Impact factor: 4.530

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.